CPL @1098 (91.2%) on 21-jan-2018 [ "provider recommends taking _" "side effects are possible with _" "cancer drug called _" "new drug called _" "shared decision about _" "generic alternative to _" "_ is considered a pregnancy Category D medication" "specific drug interactions with _" "violative promotional materials for _" "_ is an effective drug" "drugs like _" "healthcare provider recommends taking _" "chemotherapy drugs like _" "effects are possible with _" "drugs such as _" "_ currently expires in" "_ was given a pregnancy Category D rating" ] using abraxane
SEAL @238 (75.0%) on 18-apr-2011 [ 12 ] using abraxane
CPL @1112 (52.2%) on 19-jul-2018 [ "provider recommends taking _" "drug called _" "side effects are possible with _" "chemotherapy called _" "chemotherapeutics such as _" "cancer drug called _" "shared decision about _" "generic alternative to _" "_ is considered a pregnancy Category D medication" "drug interactions Do _" "specific drug interactions with _" "_ was not mutagenic" "violative promotional materials for _" "_ is an effective drug" "drugs like _" "healthcare provider recommends taking _" "_ 's active ingredient" "chemotherapy drugs like _" "effects are possible with _" "drugs such as _" "_ currently expires in" "Skin accidentally exposed to _" "_ is a chemotherapy agent" "_ was given a pregnancy Category D rating" ] using abraxane
SEAL @224 (98.4%) on 24-mar-2011 [ 123456 ] using abraxane
CMC @992 (69.7%) on 27-apr-2016 [ LASTSUFFIX=ne 2.81255 SUFFIX=ne 2.22017 CHARS 1.52595 LASTSUFFIX=ane 1.24471 SUFFIX=ane 1.01771 SUFFIX=xane 0.72210 LASTSUFFIX=xane 0.69481 LASTPREFIX=ab -1.00415 PREFIX=ab -1.34231 WORDS -4.86019 ] using abraxane
MBL @325 (87.5%) on 01-jul-2011 [ Promotion of drug:abraxane drughassideeffect disease:side_effects ]
CPL @1105 (91.7%) on 25-mar-2018 [ "adverse events associated with _" "dose of _" "clinical trials with _" "FDA approval of _" "side effects of _" "patients treated with _" ] using abraxane